carvedilol has been researched along with adrenomedullin in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doughty, R; Espiner, EA; Frampton, C; MacMahon, S; Murphy, J; Nicholls, MG; Richards, AM; Sharpe, N; Yandle, TG | 1 |
Cybulski, G; KrzemiĆski, K; Mikulski, T; Nazar, K | 1 |
1 trial(s) available for carvedilol and adrenomedullin
Article | Year |
---|---|
Plasma N-terminal pro-brain natriuretic peptide and adrenomedullin: prognostic utility and prediction of benefit from carvedilol in chronic ischemic left ventricular dysfunction. Australia-New Zealand Heart Failure Group.
Topics: Adrenergic beta-Antagonists; Adrenomedullin; Biomarkers; Carbazoles; Carvedilol; Chronic Disease; Heart Failure; Humans; Natriuretic Peptide, Brain; Nerve Tissue Proteins; Peptide Fragments; Peptides; Prognosis; Propanolamines; Risk Factors; Ventricular Dysfunction, Left | 2001 |
1 other study(ies) available for carvedilol and adrenomedullin
Article | Year |
---|---|
Effect of adrenergic blockade on plasma adrenomedullin concentration during static handgrip in patients with heart failure.
Topics: Adrenergic beta-Antagonists; Adrenomedullin; Aged; Analysis of Variance; Biomarkers; Blood Pressure; Carbazoles; Cardiac Output; Carvedilol; Chronic Disease; Coronary Artery Disease; Epinephrine; Exercise Test; Heart Failure; Heart Rate; Humans; Linear Models; Male; Middle Aged; Norepinephrine; Propanolamines; Sympathetic Nervous System; Treatment Outcome; Vascular Resistance | 2006 |